Cover Image

Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure

Decreased levels of matrix metalloproteinases (MMPs) or excess levels of their tissue inhibitors (TIMPs) may contribute to dysregulation of extracellular matrix turnover in systemic sclerosis (SSc). In a cross-sectional study of 106 SSc patients, we measured serum levels of TIMP-4 which is preferent...

Full description

Saved in:

Bibliographic Details
Main Authors:	Gialafos J. Elias (Author), Moyssakis Ioannis (Author), Psaltopoulou Theodora (Author), Papadopoulos P. Dimitrios (Author), Perea Despoina (Author), Vlasis Kostantinos (Author), Kostopoulos Charalampos (Author), Votteas Vassilios (Author), Sfikakis P. Petros (Author)
Format:	Book
Published:	Hindawi Limited, 2008-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP
by: Uldbjerg Niels, et al.
Published: (2008)

Expression of matrix metalloproteinases (MMP-1, MMP-2 and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in oral submucous fibrosis
by: Rajendran R, et al.
Published: (2006)

Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis
by: Małgorzata Kobusiak-Prokopowicz, et al.
Published: (2021)

Expression of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors (TIMPs) in Frozen Sperm of Rabbit
by: Sang Hwan Kim, et al.
Published: (2019)

Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure
by: Nissi Ritva, et al.
Published: (2013)

Urinary Metalloproteinases-9 and -2 and Their Inhibitors TIMP-1 and TIMP-2 are Markers of Early and Long-Term Graft Function After Renal Transplantation
by: Ewa Kwiatkowska, et al.
Published: (2016)

Immunohistochemical characterization of the expression of matrix metalloproteinase - 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in the invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2015)

Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma
by: Talvensaari-Mattila Anne, et al.
Published: (2010)

Temporal and spatial expression of tissue inhibitors of metalloproteinases 1 and 2 (TIMP-1 and -2) in the bovine corpus luteum
by: Moses Marsha A, et al.
Published: (2003)

Tissue Inhibitor of Metalloproteinase 3 (TIMP3) mutations increase glycolytic activity and dysregulate glutamine metabolism in RPE cells
by: Allison Grenell, et al.
Published: (2024)

Correlation of Endostatin and Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Serum Levels With Cardiovascular Involvement in Systemic Sclerosis Patients
by: Bozena Dziankowska-Bartkowiak, et al.
Published: (2005)

THE ROLE OF MATRIX METALLOPROTEINASE MMP-9, ITS INHIBITOR TIMP-1 AND INTERLEUKINE-1β IN PATHOGENESIS OF TRAUMATIC BRAIN INJURY
by: S. V. Ziablitsev, et al.
Published: (2016)

THE ROLE OF MATRIX METALLOPROTEINASE MMP-9, ITS INHIBITOR TIMP-1 AND INTERLEUKINE-1β IN PATHOGENESIS OF TRAUMATIC BRAIN INJURY
by: S. V. Ziablitsev, et al.
Published: (2016)

Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus
by: Lucia Saucedo, et al.
Published: (2021)

Circulating Tissue Inhibitor of Metalloproteinase-4 levels are not a Predictor of Preeclampsia in the period between 20 and 25 Weeks of Gestation
by: Valeria Cristina Sandrim, et al.
Published: (2018)

TIMP way to stop metastasis?
by: Katarzyna Jarosz, et al.
Published: (2017)

TIMP way to stop metastasis?
by: Katarzyna Jarosz, et al.
Published: (2017)

Use of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in the pathomorphological diagnosis of carotid pathology: literature review and own observations
by: Yu. I. Kuzyk
Published: (2016)

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer
by: Aneta Cymbaluk-Płoska, et al.
Published: (2018)

Analysis of TIMP-1 expression in leukoplakia and oral squamous cell carcinoma
by: Susy Carmelita P. Nascimento, et al.

4-Hydroxyisoleucine ameliorates an insulin resistant-like state in 3T3-L1 adipocytes by regulating TACE/TIMP3 expression
by: Gao F, et al.
Published: (2015)

Retinol-binding protein 4 (RBP4) circulating levels and gestational diabetes mellitus: a systematic review and meta-analysis
by: Bianca M. Leca, et al.
Published: (2024)

Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus
by: Ewa Robak, et al.
Published: (2006)

Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus
Published: (2006)

Colchicine modulates TIMP1, MMP1, and pMAP4 expression to enhance extracellular matrix degradation in 3T3 fibroblast-mediated myocardial infarction
by: Saskia Dyah Handari, et al.
Published: (2024)

Inhibition Effect of Physalis angulata Leaf Extract on Viability, Collagen Type I, and Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) but Not Plasminogen Activator Inhibitor-1 (PAI-1) of Keloid Fibroblast Culture
by: Widiatmoko A, et al.
Published: (2023)

Excessive Tongue Amyloidosis as the Diagnostic Sign of Multiple Myeloma: a Case Report
by: Dalampiras Stylianos, et al.
Published: (2015)

Syntheses of Radioiodinated Pyrimidine-2,4,6-Triones as Potential Agents for Non-Invasive Imaging of Matrix Metalloproteinases
by: Hans-Jörg Breyholz, et al.
Published: (2017)

4-(Indol-3-yl)thiazole-2-amines and 4-ιndol-3-yl)thiazole Acylamines as Νovel Antimicrobial Agents: Synthesis, In Silico and In Vitro Evaluation
by: Sergei Simakov, et al.
Published: (2021)

Relationship of MMP-14 and TIMP-3 Expression with Macrophage Activation and Human Atherosclerotic Plaque Vulnerability
by: Jason L. Johnson, et al.
Published: (2014)

Gamification concepts for leveraging knowledge sharing in Industry 4.0
by: Maria Tsourma, et al.
Published: (2019)

TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice
by: Robert Stöhr, et al.
Published: (2015)

Dinamica mortalității prin tuberculoză în diferite perioade de timp.
by: Ion Haidarlî, et al.
Published: (2019)

Chapter 4 Galen in Byzantine Medical Literature
by: Bouras-Vallianatos, Petros
Published: (2019)

Chapter 4 Galen in Byzantine Medical Literature
by: Bouras-Vallianatos, Petros
Published: (2019)

Liuweibuqi capsules improve pulmonary function in stable chronic obstructive pulmonary disease with lung-qi deficiency syndrome by regulating STAT4/STAT6 and MMP-9/TIMP-1
by: Dan-Dan Shen, et al.
Published: (2019)

Ezh2 Inhibits Replicative Senescence of Atrial Fibroblasts Through Promotion of H3K27me3 in the Promoter Regions of CDKN2a and Timp4 Genes
by: Li Y, et al.
Published: (2022)

Promoter Methylation of p16INK4A, hMLH1, and MGMT in Liquid-Based Cervical Cytology Samples Compared with Clinicopathological Findings and HPV Presence
by: Aris Spathis, et al.
Published: (2011)

Desquamative gingivitis: Clinical and epidemiological findings in patients from Northern Greece
by: Chatzisymeonidou Soultana, et al.
Published: (2023)

Influence of phase I periodontal therapy on levels of matrix metalloproteinase 1 and tissue inhibitor of metalloproteinase 1
by: Pallavi S. Ghodpage, et al.
Published: (2014)